Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 0 | 0 | 303 | 232 | 0 |
| Operating Income | N/A | N/A | -303 | -232 | N/A |
| Interest Expense | 0 | 0 | 6 | 7 | 0 |
| Other Income | 0 | 0 | -841 | 525 | 0 |
| Pre-tax Income | 0 | 0 | -1,150 | 286 | 0 |
| Net Income Continuous | N/A | N/A | -1,150 | 286 | N/A |
| Net Income | $N/A | $N/A | $-1,150 | $286 | $N/A |
| EPS Basic Total Ops | N/A | N/A | -0.22 | 0.05 | N/A |
| EPS Basic Continuous Ops | N/A | N/A | -0.22 | 0.05 | N/A |
| EPS Diluted Total Ops | N/A | N/A | -0.22 | 0.05 | N/A |
| EPS Diluted Continuous Ops | N/A | N/A | -0.22 | 0.05 | N/A |
| EPS Diluted Before Non-Recurring Items | 0.40 | -0.10 | N/A | N/A | 0.04 |
| EBITDA(a) | $N/A | $N/A | $-303 | $-232 | $N/A |